๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Oral vs IV etoposide in non-Hodgkin's lymphoma


Book ID
120844558
Publisher
Adis International Limited (now part of Wolters Kluwer Health)
Year
2008
Weight
133 KB
Volume
&NA;
Category
Article
ISSN
1173-8324

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Oral idarubicin in non-Hodgkin's lymphom
โœ Massimo Lopez; Luigi Lauro; Paola Papaldo ๐Ÿ“‚ Article ๐Ÿ“… 1986 ๐Ÿ› Springer US ๐ŸŒ English โš– 310 KB

Idarubicin (DMDR), a new analogue of daunorubicin, was administered orally once every 3 weeks at the dose of 40 to 45 mg/m 2 to 20 evaluable patients with non-Hodgkin's lymphomas (NHL). Eighty-six percent of patients with favorable histology and 54% with unfavorable histology (intermediate and high

Oral mucosal non-Hodgkinโ€™s lymphoma
โœ Pรญa Lรณpez-Jornet; Ambrosio Bermejo-Fenoll ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 373 KB
Dendritic cells in oral non-hodgkinโ€™s ly
โœ S.O.M. Sousa; R.A. Mesquita; V.C. Araรบjo; R.A.P. Paes; N.S. Araรบjo ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 35 KB